TrialClinical cancer research : an official journal of the American Association for Cancer Research2015

Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma.

Christine E Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.